Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NT Life Sciences
Culver City, CA, USAntlifesciences.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NT Life Sciences is a biopharmaceutical joint venture established by NantWorks and Merz Pharma to develop and commercialize innovative therapies in the fields of neurology and aesthetics. The company's primary focus is on the development of NT-0201 (incobotulinumtoxinA), a botulinum toxin type A marketed as Xeomin, for expanded indications such as sialorrhea. Additionally, NT Life Sciences is advancing NT-0502, a novel small molecule muscarinic antagonist designed to treat chronic sialorrhea by reducing excessive salivation. The company leverages the combined expertise of Merz in neurotoxin research and NantWorks in molecular medicine and data-driven healthcare. NT Life Sciences also operates a joint venture with The Times Group to bring advanced healthcare technologies to the Indian market.
- Therapeutic areas
- NeurologyDermatology
- Modalities
- BiologicSmall moleculeProtein
- Industry
- Biotech
02
Partnerships
Merz PharmaThe Times Group
Beyond the preview
Go deeper on NT Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NT Life Sciences.